Vincent Brancaccio - 26 May 2021 Form 3 Insider Report for Singular Genomics Systems, Inc. (OMIC)

Role
Vice President, HR
Signature
/s/ Vincent Brancaccio
Issuer symbol
OMIC
Transactions as of
26 May 2021
Net transactions value
$0
Form type
3
Filing time
26 May 2021, 20:32:47 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OMIC Common Stock 32,500 26 May 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OMIC Employee Stock Option (right to buy) 26 May 2021 Common Stock 25,000 $8.95 Direct F1
holding OMIC Employee Stock Option (right to buy) 26 May 2021 Common Stock 40,000 $0.6900 Direct F2
holding OMIC Employee Stock Option (right to buy) 26 May 2021 Common Stock 87,500 $0.6300 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option granted under the Singular Genomics Systems, Inc. 2016 Stock Plan. The option shares vest and become exercisable in 48 equal monthly installments beginning on April 1, 2021.
F2 Option granted under the Singular Genomics Systems, Inc. 2016 Stock Plan. The option shares vest and become exercisable in 48 equal monthly installments beginning on October 23, 2020.
F3 Option granted under the Singular Genomics Systems, Inc. 2016 Stock Plan. 25% of the the option shares vest and become exercisable on September 23, 2020, the remainder of the option shares vest in 36 equal monthly installments thereafter, beginning on October 23, 2020.

Remarks:

Exhibit 24 - Power of Attorney